107.33 -0.09 (-0.08%)
After hours: 4:00PM EST
Previous Close | 108.02 |
Open | 107.84 |
Bid | 107.38 x 1000 |
Ask | 107.38 x 1200 |
Day's Range | 106.71 - 108.85 |
52 Week Range | 72.29 - 117.68 |
Volume | 233,669 |
Avg. Volume | 423,057 |
Market Cap | 7.13B |
Beta (5Y Monthly) | 0.60 |
PE Ratio (TTM) | 29.75 |
EPS (TTM) | 3.61 |
Earnings Date | Apr 29, 2021 - May 03, 2021 |
Forward Dividend & Yield | 0.88 (0.83%) |
Ex-Dividend Date | Dec 15, 2020 |
1y Target Est | 122.43 |
Hillrom (NYSE: HRC) today announced that it will present at the Barclays Global Healthcare Conference on Wednesday, March 11, 2021. John Groetelaars, Hillrom's president and chief executive officer, will participate in a fireside chat at 9:45 a.m. Eastern Time via webcast and will host virtual one-on-one meetings immediately following.
Hill-Rom's (HRC) first-quarter fiscal 2021 revenue climbed 8.2% year over year to $741.1 million.
Shares of Hill-Rom Holdings (NYSE:HRC) rose 0.1% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 35.40% year over year to $1.53, which beat the estimate of $1.05. Revenue of $741,100,000 rose by 8.19% from the same period last year, which beat the estimate of $654,410,000. Guidance Earnings guidance hasn't been issued by the company for now. Hill-Rom Holdings hasn't issued any revenue guidance for the time being. Conference Call Details Date: Feb 05, 2021 View more earnings on HRC Time: 08:30 AM ET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Fir.hill-rom.com%2F&eventid=2947795&sessionid=1&key=B4896A67EE09F14F84A6F7327B4C45F0®Tag=&V2=false&sourcepage=register Technicals 52-week high: $117.68 52-week low: $72.29 Price action over last quarter: Up 3.31% Company Description Hill-Rom Holdings Inc is a global provider of hospital equipment and medical supplies, including hospital beds for high- and low-acuity settings. Hill-Rom reports financial data across three operating segments: patient support systems (50% of fiscal 2018 sales), front-line care (34%), and surgical solutions (16%). The firm has significant operations internationally, with roughly 30% of revenue derived from international sources and the remaining 70% from its U.S. business. See more from BenzingaClick here for options trades from BenzingaEarnings Scheduled For February 5, 2021Hill-Rom Holdings's Earnings Outlook© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.